Zoetis to draw from revolver for $765 million Pharmaq acquisition

By Wendy Van Sickle,

Columbus, Ohio, Nov. 2 – Zoetis Inc. plans to draw on its revolving credit facility to fund its purchase of Pharmaq, according to a press release.

Zoetis expects to complete the $765 million acquisition on or about Nov. 10.

Based in New York, Zoetis makes animal health medicines and vaccines. Based in Norway, Pharmaq is a maker of vaccines and health products for aquaculture.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.